Agile Therapeutics, Inc.

AGRX · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$2,848$2,615$2,557$2,873
Short-Term Investments$0$0$0$0
Receivables$4,550$4,813$3,392$3,521
Inventory$5,793$3,748$2,738$2,411
Other Curr. Assets$1,118$631$402$562
Total Curr. Assets$14,443$11,987$9,530$10,064
Property Plant & Equip (Net)$282$385$487$587
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$238$238$238$238
Total NC Assets$520$623$725$825
Other Assets$0$0$0$0
Total Assets$14,963$12,610$10,255$10,889
Liabilities
Payables$16,543$12,620$9,574$6,879
Short-Term Debt$0$0$1,706$2,321
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$954$908$832$2,368
Total Curr. Liab.$26,228$21,441$20,777$17,538
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$10,647$1,493$5,696$5,566
Total NC Liab.$10,647$1,493$5,796$5,762
Other Liabilities$0$0$0$0
Cap. Leases$289$378$466$549
Total Liabilities$36,875$22,934$26,573$23,300
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$4$0
Retained Earnings-$433,756-$421,884-$423,168-$418,699
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity-$21,912-$10,324-$16,318-$12,411
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$14,963$12,610$10,255$10,889
Net Debt-$2,848-$2,615-$851-$552
Agile Therapeutics, Inc. (AGRX) Financial Statements & Key Stats | AlphaPilot